XML 123 R106.htm IDEA: XBRL DOCUMENT v3.24.3
Note 18 - Segment and Geographic Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Total revenue $ 656,323 $ 665,072 $ 555,498
Segment adjusted operating income (loss) (200,678) (73,126) (24,735)
Amortization of intangible assets 51,300 48,400 32,300
Purchase accounting impact on inventory 0 9,664 0
Transformation(1) and rebranding costs 13,856 (49) 2,741
Restructuring charges 11,808 4,577 712
Impairment of Intangible Assets and Goodwill 115,975 0 0
Contingent consideration - fair value adjustments 0 (18,549) 600
Business Combination, Acquisition Related Costs [1] 4,874 13,842 17,329
Interest income, net 33,177 43,735 15,697
Other Nonoperating Income (Expense) 178 (1,042) (898)
Loss before income taxes (167,323) (30,433) (9,936)
Developed Technology Rights [Member]      
Amortization of intangible assets 24,770 18,494 7,324
Excluding Completed Technology [Member]      
Amortization of intangible assets 26,500 29,884 24,965
Operating Segments [Member]      
Segment adjusted operating income (loss) (2,823) (15,209) 29,002
Sample Management Solutions [Member]      
Total revenue 318,646 303,654 304,561
Restructuring charges 3,200    
Sample Management Solutions [Member] | Operating Segments [Member]      
Segment adjusted operating income (loss) 10,841 (2,349) 23,970
Multiomics [Member]      
Total revenue 254,552 248,296 250,937
Multiomics [Member] | Operating Segments [Member]      
Segment adjusted operating income (loss) (7,995) (13,779) 5,032
B Medical Systems S.a.r.l. [Member]      
Total revenue 83,125 113,122 0
Restructuring charges 5,300    
B Medical Systems S.a.r.l. [Member] | Operating Segments [Member]      
Segment adjusted operating income (loss) (5,669) 919 0
Corporate Segment [Member]      
Restructuring charges 3,300    
Other unallocated corporate expenses $ 72 $ 54 $ 66
[1] Includes expenses related to governance-related matters.